Similar articles

• Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.

  Atkinson K, Downs K, Ashby M, Biggs J. Atkinson K, et al. Transplant Proc. 1990 Jun;22(3):1331-4. Transplant Proc. 1990. PMID: 2190395 No abstract available.
• Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.

  Truog AW, Wozniak SP. Truog AW, et al. Oncol Nurs Forum. 1990 Jan-Feb;17(1):39-44. Oncol Nurs Forum. 1990. PMID: 2405360 Review.
• The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.

  Britton K, Atkinson K, Downs K, Biggs J. Britton K, et al. Transplant Proc. 1985 Apr;17(2):1667-70. Transplant Proc. 1985. PMID: 3885501 No abstract available.
• Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

  Gluckman E, Devergie A, Lokiec F. Gluckman E, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):461-9. Transplant Proc. 1988. PMID: 3291282 No abstract available.
• Cyclosporin A (CsA): pharmacokinetics, clinical monitoring and pharmacodynamics in bone marrow transplantation (BMT).

  Carreras Pons E. Carreras Pons E. Prog Clin Biol Res. 1989;309:325-32. Prog Clin Biol Res. 1989. PMID: 2675101 Review. No abstract available.